Amundi Asset Management US’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $4.03M | Buy |
327,785
+223,500
| +214% | +$2.74M | ﹤0.01% | 1061 |
|
2020
Q4 | $1.49M | Sell |
104,285
-172,450
| -62% | -$2.46M | ﹤0.01% | 1161 |
|
2020
Q3 | $3.85M | Buy |
276,735
+95,075
| +52% | +$1.32M | ﹤0.01% | 960 |
|
2020
Q2 | $1.93M | Buy |
181,660
+77,375
| +74% | +$820K | ﹤0.01% | 1074 |
|
2020
Q1 | $842K | Sell |
104,285
-2,900
| -3% | -$23.4K | ﹤0.01% | 1114 |
|
2019
Q4 | $870K | Sell |
107,185
-163,680
| -60% | -$1.33M | ﹤0.01% | 1251 |
|
2019
Q3 | $2.05M | Buy |
270,865
+16,680
| +7% | +$126K | ﹤0.01% | 1080 |
|
2019
Q2 | $1.91M | Sell |
254,185
-12,000
| -5% | -$89.9K | ﹤0.01% | 1130 |
|
2019
Q1 | $2.16M | Buy |
266,185
+110,000
| +70% | +$891K | ﹤0.01% | 1056 |
|
2018
Q4 | $1.18K | Buy |
156,185
+86,000
| +123% | +$648 | ﹤0.01% | 1117 |
|
2018
Q3 | $486K | Buy |
70,185
+15,500
| +28% | +$107K | ﹤0.01% | 1329 |
|
2018
Q2 | $352K | Hold |
54,685
| – | – | ﹤0.01% | 1382 |
|
2018
Q1 | $357K | Sell |
54,685
-27,980
| -34% | -$183K | ﹤0.01% | 1308 |
|
2017
Q4 | $621K | Buy |
+82,665
| New | +$621K | ﹤0.01% | 1258 |
|